APA (7th ed.) Citation

JE, P., WC, S., HJ, L., D, Y., DY, S., CH, A., . . . DY, L. (2023). SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo. Phytotherapy research : PTR, 37(2), 452. https://doi.org/10.1002/ptr.7626

Chicago Style (17th ed.) Citation

JE, Park, et al. "SH-PRO Extract Alleviates Benign Prostatic Hyperplasia via ROS-mediated Activation of PARP/caspase 3 and Inhibition of FOXO3a/AR/PSA Signaling in Vitro and in Vivo." Phytotherapy Research : PTR 37, no. 2 (2023): 452. https://doi.org/10.1002/ptr.7626.

MLA (9th ed.) Citation

JE, Park, et al. "SH-PRO Extract Alleviates Benign Prostatic Hyperplasia via ROS-mediated Activation of PARP/caspase 3 and Inhibition of FOXO3a/AR/PSA Signaling in Vitro and in Vivo." Phytotherapy Research : PTR, vol. 37, no. 2, 2023, p. 452, https://doi.org/10.1002/ptr.7626.